Obtaining Technetium-99m-Labeled Glucose Derivatives

Abstract:

The possibility of obtaining and using technetium-99m-labeled glucose derivatives for the diagnosis of malignant tumors by the method of single photon emission computed tomography (SPECT) has been considered. The level of international and domestic developments on this topic has been analyzed. The authors made an attempt to develop pilot batches of lyophilizates on the basis of various glucose derivatives for further obtaining appropriate radiopharmaceuticals (RPC).

• Periodical: Advanced Materials Research (Volume 1084)
• Pages: 567-571
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.1084.567
• Online since: January 2015
• Authors: Viktor S. Skuridin*, Elena S. Stasyuk, Ekaterina A. Ilyina, Alexander S. Rogov
• Keywords: Glucose, Radiopharmaceutical, RPC, Technetium-99m

References

[1] V.S. Skuridin, A.S. Semenov, Preparation of radionuclide labeled glucose derivative for the diagnosis of cancer, News of Higher Educational Institutions. Physics (in Russian). 56, 4/2 (2013) 264-267.

[2] H.K. Lee, D.H. Moon, J.S. Ryu, J.S. Kim, S.J. Oh, U.S. Patent 2003/0120046 A. (2003).

[3] S. K. Ozker, B.D. Collier, U.S. Patent 06099822A. (2000).

[4] Y. Chen, Z.W. Huang, L. He, S.L. Zheng, J.L. Li, D.L. Qin, Synthesis and evaluation of a technetium-99m-labeled diethylentriaminepentaacetate-deoxyglucose complex 99mTc-DTPA-DG as a potential imaging modality for tumors, J. Appl. Radiat. and Isot. 64(3) (2006).

DOI: 10.1016/j.apradiso.2005.08.004

[5] X. Chen, L. Li, F. Liu, B. Liu, Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor, J. Bioorg. Med. Chem. Lett. 16 (21) (2006) 5503–5506.

DOI: 10.1016/j.bmcl.2006.08.050

[6] D. Cheng, M. Rusckowski, Y. Wang, Y. Liu, G. Liu, X. Liu, D. Hnatowich, A Brief Evaluation of Tumor Imaging in Mice with 99mTc-glucarate Including a Comparison with 18F-FDG, J. Curr. Radiopharm., 4 (1) (2011) 5-9.

DOI: 10.2174/1874471011104010005

[7] M.M. Welling, R. Alberto, Performance of a 99mTc-labelled 1-thio-beta-D-glucose 2, 3, 4, 6-tetra-acetate analogue in the detection of infections and tumours in mice: a comparison with [18F]FDG, J. Nucl. Med. Commun., 31(3) (2010) 239-248.

DOI: 10.1097/mnm.0b013e32833501e4

[8] D.J. Yang, C.G. Kim, N.R. Schechter, A. Azhdarinia, D.F. Yu, C.S. Oh, J.L. Bryant, J.J. Won, E.E. Kim, D.A. Podoloff, Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents, J. Radiology. 226 (2) (2003).

DOI: 10.1148/radiol.2262011811

[9] S.J. Oh, J.S. Ryu, E.J. Yoon, M.S. Bae, S.J. Choi, K.B. Park, D.H. Moon, 99mTc-labeled 1-thio-beta-D-glucose as a new tumor-seeking agent: synthesis and tumor cell uptake assay, J. Appl. Radiat. and Isot. 64(2) (2006) 207-215.

DOI: 10.1016/j.apradiso.2005.07.022